Clinical Trial Update: Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ [Phase 3]

View source ↗

Summary

Phase 3 trial updating primary vaccination with Synflorix or Prevnar 13 or both, and booster with Synflorix; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease
• Streptococcal Infections
• Streptococcus Pneumoniae Infection

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)
• Synflorix (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2017-02-27